» Articles » PMID: 18639376

MicroRNAs in the Pathogenesis of Neuroblastoma

Overview
Journal Cancer Lett
Specialty Oncology
Date 2008 Jul 22
PMID 18639376
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs constitute a family of small RNA species that regulate translation and stability of mRNA. This additional layer of epigenetic regulation has escaped discovery until recently, and introduces another level between mRNA expression profiling and proteomics. Since microRNAs are involved in regulating most, if not all cellular processes, their involvement in oncogenesis was anticipated. Indeed, soon after their discovery, microRNAs were found to act as tumor suppressor genes by blocking the translation of oncogenes and act as oncogenes by inhibiting the translation of tumor suppressor genes. Here we review the most recent attempts aiming to analyze the functional roles of microRNAs in neuroblastoma, the most devastating solid tumor in childhood.

Citing Articles

MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.

Aravindan N, Subramanian K, Somasundaram D, Herman T, Aravindan S Cancer Drug Resist. 2019; 2:1086-1105.

PMID: 31867575 PMC: 6924638. DOI: 10.20517/cdr.2019.68.


Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma.

Fuchs S, Naderi J, Meggetto F Int J Mol Sci. 2019; 20(9).

PMID: 31052302 PMC: 6539248. DOI: 10.3390/ijms20092150.


MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of , and .

Roth S, Hald O, Fuchs S, Lokke C, Mikkola I, Flaegstad T Oncotarget. 2018; 9(26):18160-18179.

PMID: 29719597 PMC: 5915064. DOI: 10.18632/oncotarget.24793.


MiRNA Influences in Neuroblast Modulation: An Introspective Analysis.

Zammit V, Baron B, Ayers D Genes (Basel). 2018; 9(1).

PMID: 29315268 PMC: 5793179. DOI: 10.3390/genes9010026.


A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma.

De Mariano M, Stigliani S, Moretti S, Parodi F, Croce M, Bernardi C Oncotarget. 2017; 8(34):56518-56532.

PMID: 28915608 PMC: 5593579. DOI: 10.18632/oncotarget.17033.